Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 1)

Adenocarcinoma, Papillary (Phase 1)

Bronchial Diseases (Phase 3)

Bronchial Neoplasms (Phase 1)

Carcinoma (Phase 3)

Carcinoma, Bronchogenic (Phase 3)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Neuroendocrine (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Colonic Diseases (Phase 1)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 1)

Digestive System Diseases (Phase 1)

Digestive System Neoplasms (Phase 1)

Endocrine Gland Neoplasms (Phase 1)

Endocrine System Diseases (Phase 1)

Gastrointestinal Diseases (Phase 1)

Gastrointestinal Neoplasms (Phase 1)

Gastrointestinal Stromal Tumors (Phase 3)

Head and Neck Neoplasms (Phase 3)

Hematologic Neoplasms (Phase 2)

Intestinal Diseases (Phase 1)

Intestinal Neoplasms (Phase 1)

Leukemia, Mast-Cell (Phase 2)

Lung Diseases (Phase 3)

Lung Neoplasms (Phase 3)

Mastocytosis (Phase 2)

Mastocytosis, Systemic (Phase 2)

Neoplasms (Phase 3)

Neoplasms by Histologic Type (Phase 3)

Neoplasms by Site (Phase 3)

Neoplasms, Germ Cell and Embryonal (Phase 3)

Neoplasms, Glandular and Epithelial (Phase 1)

Neoplasms, Nerve Tissue (Phase 3)

Neuroectodermal Tumors (Phase 1)

Neuroectodermal Tumors, Primitive (Phase 1)

Neuroendocrine Tumors (Phase 1)

Respiratory Tract Diseases (Phase 3)

Respiratory Tract Neoplasms (Phase 3)

Thoracic Neoplasms (Phase 3)

Thyroid Cancer, Papillary (Phase 1)

Thyroid Diseases (Phase 1)

Thyroid Neoplasms (Phase 1)